Own stem cells show promise in controlling leukemia after first remission
NCT ID NCT00534469
First seen Jan 05, 2026 · Last updated May 17, 2026 · Updated 20 times
Summary
This study tested a treatment for adults with acute myeloid leukemia (AML) who were in their first remission. Patients received high-dose chemotherapy and radiation, followed by a transplant of their own previously collected stem cells, plus an immune-boosting drug after transplant. The goal was to see if this approach could keep the leukemia from coming back. The trial involved 60 participants and focused on survival without the disease returning two years later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.